Permira exits life sciences company for $3.51bn

Side Letter: Blended buyouts

Deep Dive: Why Asia-Pacific private equity is shifting from growth to control

Ardian bets on the ‘power of live’ in latest buyout fund

Japanese GP returns entire debut fund with first exit

Carlyle leans into carve-outs as dealmaking gets more competitive

Number Crunch: The road to cyber resilience

Why growth and buyout strategies are becoming harder to distinguish